Results 121 to 130 of about 9,289 (204)
Serosurveillance Identifies an Endemic Hotspot of Lassa Fever in Faranah, Upper Guinea. [PDF]
J Infect DisMariën J, Nuismer SL, Magassouba N, Soropogui B, Günther S, Becker-Ziaja B, Gabriel M, Müller-Kräuter H, Strecker T, Saez AM, Borchert M, Fichet-Calvet E. +11 moreeuropepmc +1 more sourcePresence of Lassa Virus RNA in Cerebrospinal Fluid Indicating Neuroinvasive Lassa Fever in Pediatric Patients From Edo State, Nigeria. [PDF]
J Infect DisMüller HCS, Erameh CO, Okoeguale J, Ileli SO, Onyeke IF, Adetunji AE, Akerele LO, Esumeh R, Ohomoime EB, Hinrichs M, Müller J, Aiterebhe UM, Ekuma CN, Ugadu CO, Onyerikam IH, Idialu-Eigbobo JO, Apeleokha M, Ehiaghe E, Edeawe OI, Iraoyah KO, Hoffmann C, Adomeh D, Olokor T, Odia I, Asogun D, Okogbenin S, Ogbaini-Emovon E, Eifediyi R, Günther S, Pahlmann M, Ramharter M, Oestereich L, Omansen T, Akpede G. +33 moreeuropepmc +1 more sourceIn-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein. [PDF]
Sci RepEyo AE, Edet UO, Abdalla M, Bassey IU, Al-Shouli S, Mbim E, Alghamdi H, Kurdee Z, Alrukhayes M, Imalele EE, Reuben OE, Nwaokorie F, Meseko C. +12 moreeuropepmc +1 more sourceDecoding the human CD4<sup>+</sup> T cell epitope repertoire for Lassa fever virus reveals T cell-based pan-mammarenavirus vaccine candidates. [PDF]
Cell Rep MedLee Y, Siddiqui L, Tarke A, Kim M, Michaelis T, Macias M, Phillips E, Mallal S, Trevizani R, Frazier A, Scheuermann RH, Zuniga A, Zmasek C, Spurgers K, Akintunde G, Stonier SW, Gagliardi TB, Warfield K, Li H, Hastie KM, Saphire EO, Tan GS, Grifoni A, Sette A. +23 moreeuropepmc +1 more sourceEfficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates. [PDF]
PLoS OneBardach A, Berrueta M, Ciapponi A, Sambade JM, Castellana N, Ballivian J, Brizuela M, Caravario J, Comande D, Couto E, Mazzoni A, Ortega V, Parker EPK, Salva F, Stegelmann K, Schieffelin JS, Xiong X, Stergachis A, Munoz FM, Buekens P. +19 moreeuropepmc +1 more sourceThe First Imported Case of Lassa Fever - China, 2024. [PDF]
China CDC WklyWang Y, Wen X, Li D, Fan S, Zhou X, Yan K, Cao J, Li J, Wei R, Liu H, Wu W, Zheng S, Jiang R, Peng Y, Feng Y, Xiang N, Zhou J. +16 moreeuropepmc +1 more sourceClinical Outcomes of Severe Lassa Fever in West Africa: A Systematic Review and Meta-Analysis. [PDF]
Int J Environ Res Public HealthOkwuraiwe AP, Onyeaghala CA, Ozoude OT, Suleiman MO, Abdu-Aguye SN, Ezekwelu NJ, Oyeniyi TA, Jegede AO, Egwudo AE, Okeke OP, Abodunrin OR, Akinsolu FT, Sobande OO. +12 moreeuropepmc +1 more sourceLassa fever research priorities : towards effective medical countermeasures by the end of the decade
: In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote development of effective medical countermeasures (ie, diagnostics ...Fichet-Calvet, Elisabeth, Gupta, Swati B., Roth, Cathy, Preziosi, Marie-Pierre, Grant, Donald S., Asogun, Danny A., Gunther, Stephan, Ampofo, William K., Bausch, Daniel G., Formenty, Pierre B.H., Osterholm, Michael T., Adetifa, Ifedayo M., Moua, Nicolina M., Emperador, Devy M., Jaspard, Marie, Barrett, Alan D.T., Feldmann, Heinz, Mehr, Angela J., Johnson, Rebecca A., Benassi, Virginia, Mazzola, Laura T., Schmaljohn, Connie S., De Coster, Ilse, Akpede, George O., Fay, Petra C., Golding, Josephine P., Ulrich, Angela K., Okogbenin, Sylvanus A., Ostrowsky, Julia T., Moore, Kristine A., Garry, Robert F., Hart, Peter J. +31 morecore CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques. [PDF]
JCI InsightPrévost J, Tailor N, Soule G, Audet J, Deschambault Y, Vendramelli R, Prado-Smith J, Tierney K, Azaransky K, Kobasa D, Clancy CS, Feldmann H, Rosenke K, Safronetz D. +13 moreeuropepmc +1 more source
